Data Safety Monitoring Board Guidance To Provide Rules For Halting Trials
Executive Summary
FDA's draft guidance on data safety monitoring boards will address when clinical trials should be stopped for safety or efficacy reasons.
You may also be interested in...
Office for Human Research Trials
David LePay, MD/PhD, will head the new office as senior advisor for clinical science. LePay had been on detail as acting senior advisor for clinical science in the Office of Science Coordination and Communication while establishing the new office (1"The Pink Sheet" March 26, p. 28)
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011